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Abstract—Hypercapnia is often used to accelerate emer-
gence from general anesthesia in the operating room, but
little is known about the postoperative effects that may
carry over to recovery in the post anesthesia care unit.
We have designed two studies to address this topic, one
of which has been completed. The first study monitored
22 patients undergoing eye surgery who received general
anesthesia using desflurane . During emergence, half of
the patients were hypercapnic and ventilated at twice
their minute volume. After the desflurane was turned
off the hypercapnic group open their eyes on command
4.1±1.4 min later, while the control group took 6.5±2.3
min. The hypercapnic group was also able to state their
first and last name, birthdate, and current year in 10.9±5.1
min; the control group took 18.2±9.7 min. In the PACU,
several subjective measures including alertness, orienta-
tion, conversant, and an Aldrete score > 8 were used
to access recovery. Hypercapnic patients faired better
in all categories. They also experienced less nausea and
received fewer doses of antiemetic. A second study has
been designed to quantify more fully the results of the first
study. Pending approval of the Institutional Review Board,
44 more patients will be monitored in a similar fashion
except that expired gas levels and ventilation parameters
will be recorded during recovery in the PACU.
INTRODUCTION
THE cardiovascular and respiratory systems workin tandem to provide the necessary gas exchange
for cellular metabolic activity throughout the body. The
respiratory system exchanges O2 and CO2 between the
atmosphere and blood; the circulatory system delivers
the O2 to cells throughout the body and transports CO2,
a byproduct of cellular respiration, from the cells back to
the lungs. When the concentration of CO2 in the blood
fluctuates, the cardiovascular and respiration systems
are adjusted to compensate. For example, if the arterial
partial pressure of CO2 (PaCO2) rises, the respiratory
rate will increase and vasodilation will occur, increasing
blood flow and gas exchange in the lungs in order to
flush the body of excess CO2. When PaCO2 is reduced,
the opposite occurs. In the operating room (OR), this
principle is frequently taken advantage of to aid patients
during recovery from general anesthesia.
Induced hypercapnia, or elevated PaCO2, can be used
to accelerate a patient’s recovery from anesthesia by
washing anesthetic vapors from the body in the same
way that excess CO2 is removed[1], [2]. A device
developed by our lab, called the QED-100 (Anecare,
Salt Lake City, UT), accomplishes this task during the
emergence phase of anesthesia in the OR[3]. The QED-
100 incorporates a rebreathing reservoir to induce hyper-
capnia and a charcoal filter to soak up expelled anesthetic
gases. Studies have shown that the QED-100 is capable
of reducing emergence times by approximately 55%[3],
[4], [5]. This result translates not only into a cost savings
from time spent in the OR, but perhaps more importantly,
it produces a patient that can enter the PACU with less
anesthetic in their system and a stronger respiratory
drive, which in turn could lead to a faster, safer, and
more satisfactory recovery.
Studies have shown that of 42,000 patients monitored,
23–24% experienced complications in the PACU, while
only 3.8–5.1% encountered difficulties in the operating
room[6], [7], [8]. One of the reasons for this is that as
a patient becomes more alert in the PACU, a greater
awareness of pain is attained, often resulting in the
administration of additional analgesics, which can react
synergistically with trace amounts of anesthetic still in
the patient’s system and induce any number of adverse
clinical events, including difficulties breathing and even
loss of consciousness. If a patient enters the PACU
with less anesthetic in their system, the probability of
encountering complications may decrease.
Although the effects of using hypercapnia during
emergence from anesthesia have been well established,
little is known about the effects that may carry over into
the PACU. We have designed two studies to address this
topic, one of which has been completed. In the first study
we hypothesized that a hypercapnic patient, entering the
PACU with less anesthetic in their system and a stronger
respiration drive, would progress through the phases of
recovery faster, experience less nausea, and require fewer
rescue antiemetics.
Owing to the success of the first study we wish to
perform a second study that further quantifies the results
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of the first. The principle difference will be that the
patient’s CO2, O2, and anesthetic gas levels as well as
tidal volume and respiratory rate will be recorded during
recovery in the PACU. We hope this data can be used
to create a numerical model that can give further insight
into how hypercapnia benefits a patient during recovery.
STUDY 1
Methods
Following Institutional Review Board (IRB) approval,
written informed consent was obtained from 22 ASA
class I-III patients of both genders scheduled to undergo
eye surgery at the John A. Moran Eye Center. Exclusion
criteria included a history of renal or hepatic disease,
chronic alcohol or drug abuse, disabling neuropsychi-
atric disorder, hypersensitivity or unusual response to
other halogenated anesthetics, pulmonary hypertension,
increased intracranial pressure, seizure disorder or per-
sonal/familial history of malignant hyperthermia.
Patients were premedicated with fentanyl and then
induced with a remifentanil infusion and a lidocaine,
propofol, and rocuronium or succinylcholine bolus at
the anesthesiologists discretion followed by tracheal in-
tubation. Anesthesia was maintained at 6% desflurane
along with a remifentanil infusion, although clinician’s
could deviate and titrate remifentanil and fentanyl as
needed during periods of increased stimulus. O2 flow
was maintained at 2 L/min, blood pressure within ±20%
of baseline, and EtCO2 at 35 mmHg (by adjusting ven-
tilation). Ondansetron 4mg was given prophylactically
before the end of surgery.
Near the end of surgery, a sealed envelope was opened
that randomly assigned the patient to either the control
or treatment group—opening the envelope at this point
prevented any bias during induction and maintenance of
anesthesia on behalf of the attending clinician. At the end
of surgery, the remifentanil infusion and desflurane were
turned off and both groups were given O2 at 10 L/min.
For the treatment group, a QED-100 was placed between
the endotracheal tube and breathing circuit and switched
on to induce mild hypercapnia. At the same time, minute
volume was doubled by doubling the respiratory rate and
adjusting tidal volume as needed. No changes were made
to the control group.
Every 30 seconds during emergence the study inves-
tigator asked the patient to open their eyes by verbal
command and gentle prodding. The time from when
anesthesia was turned off until the patient was able to
complete the task was noted.
In the PACU, a second study nurse, who was blinded
to which study group the patient was assigned, monitored
and noted the patient’s progress during the first 60
minutes of recovery. Every five minutes the study nursed
assessed whether the patient was alert, conversant, and in
pain. The patient was considered alert if they responded
to their name being called and conversant if they volun-
teered information. Pain was assessed on a scale from
0-10. If the patient’s actual pain score exceeded their
tolerable pain score, fentanyl was administered at the
discretion of the PACU nurse in increments ranging from
25-150 mcg. Every ten minutes the study nurse assessed
orientation, Aldrete score[9], and nausea. The patient
was considered oriented if they could state their first and
last name, birthdate, and current year. Questioning was
stopped after two consecutive correct answers. Nausea
was ranked as either none, mild, or moderate. The patient
was given antiemetics if the nausea persisted or increased
through two assessments and at the discretion of the
PACU nurse.
Results
Twenty-two patients were enrolled in this study who
underwent either eye muscle surgery, intraocular lens
implantation, or resection of eye lesions. Patient demo-
graphics are shown in Table I. All patients were pre-
medicated with 1.1±0.4 mcg/kg of fentanyl and induced
with 2.5±0.6 mg/kg of propofol. Drug dosing during
maintenance of anesthesia is listed in Table II.
At the end of surgery, the PetCO2 for the hypercapnic
group was 34.4±2.3 mmHg, for the control group it
was 35.1±1.5 mmHg; at extubation their PetCO2 was
36.1±6.5 and 48.1±3.8 mmHg (Table I) respectively
(note that n=6 for the hypercapnic group at extubation
because the CO2 sampling tube was misplaced).
Figure 1 shows the times to awake and oriented. The
time to awake (when the patient opened their eyes on
command) for the hypercapnic group was 4.1±1.4 min,
the control group took 6.5±2.3 min. Time to oriented
(when the patient could state their first and last name,
birth date, and current year) was 10.9±5.1 min for the
hypercapnic group and 18.2±9.7 min for the control
group. A Student t-test revealed p-values of 0.009 and
0.039 for awake and oriented respectively. A Bonferroni
correction showed that the differences for both are sta-
tistically significant.
Figure 2 shows the times to reach the various phases
of recovery. The top two plots, awake and oriented, were
already discussed in Figure 1. Alert, conversant, and Al-
drete > 8 were inherently subjective measurements made
by the blinded PACU study nurse, and as such, were
not included in the statistical analysis. The extubation
measurement was also excluded because the attending
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Fig. 1. The survival curve on the left shows the time from when anesthesia was discontinued until patients opened their eyes on verbal
command. The survival curve on the right shows how long the patients took to state their first and last name, birth date, and current year
after anesthesia was turned off. In both curves, the dark line represents the hypercapnic group, the gray represents the control group.
Fig. 2. Times to reach the various phases of recovery after desflurane anesthesia. The hypercapnic group is represented by the dark filled
boxes, the control group by the open boxes. P-values were less than 0.05 for all phases except for Aldrete > 8.
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TABLE I
PATIENT DEMOGRAPHICS: MEAN±STANDARD DEVIATION (MEDIAN)
Group Gender(F/M)
Weight
(kg) Age (yrs)
Duration
of Surgery
(min)
PetCO2at
End of
Surgery
(mmHg)
PetCO2at
Extubation
(mmHg)
Control
(n=11) 7/4
73.3±20.0
(64.6)
40.4±15.0
(40) 52±30 (43)
35.1±1.5
(35.4)
36.1±6.5
(36.7)
Treatment
(n=11) 6/5
75.8±13.0
(77.0)
43.7±15.1
(42)
90±63
(73)†
34.4±2.3
(34.1)
48.1±3.8
(48.1)‡
†Surgery for one patient in the treatment group lasted 4 hours.
‡n=6 because the sampling tube was misplaced in 5 of the cases.
TABLE II
PERIOPERATIVE AND POSTOPERATIVE DRUG DOSING FOR THE TREATMENT AND CONTROL GROUPS.
Group DesfluraneMAC-hrs
Average
MAC
MAC at
End of
Surgery
Propofol
Doses
(mg)
Fentanyl
Doses
(mcg)
Remifentanil
Infusion
Rates
(mcg/kg/min)
Fentanyl
in PACU
(mcg)
Control
(n=11)
0.82±0.46
(0.76)
0.80±0.07
(0.81)
0.77±0.16
(0.81)
1.9±0.3
(2.0)
2.36±0.92
(2.0)
0.095±0.035
(0.10)
50.0±76.6
( )
Treatment
(n=11)
1.46±1.02
(1.22)
0.81±0.08
(0.85)
0.78±0.11
(0.82)
1.8±0.2
(1.7)
2.82±1.25
(2.0)
0.11±0.016
(0.10)
25.0±33.0
( )
clinician was not blinded as to the use of the QED-100.
However, it’s worthy to note that hypercapnic patients
seem to have faired better overall during each phase of
recovery.
The nausea experienced by the patients in the PACU
is shown in Figure 3. The top charts show the duration
of the nausea and the severity as reported by the patients.
The patients have been ranked according to severity and
duration of nausea. Six control patients reported nausea,
only one of them vomitted; three hypercapnic patients
reported mild nausea. The dark gray bars represent
moderate nausea while the light gray represent mild
nausea. The bottom charts show the corresponding doses
of antiemetic given to the patients in the top charts. Six of
the control patients received antiemetics in the OR, only
one in the hypercapnic group received a single dose. It
should be noted that patient 3 in the control group and
patient 1 in the hypercapnic group experienced severe
pain and the PACU nurse chose to treat the pain and
nausea with fentanyl rather than antiemetics. Also patient
8 in the control group received ondansetron 4 mg upon
standing just before discharge from the PACU.
Discussion
When patients were hyperventilated and hypercapnic
during the emergence phase of anesthesia they woke up
2.4 min sooner than the control group—a 37% decrease
in wake up time. This result follows what was seen in a
previous study where hyperventilation and hypercapnia
shortened emergence time by 64%[2]. The differing
result between these studies may be attributed to the
fact that hypercapnic patients in the other study reached
a PetCO2 of 58 mmHg whereas the patients in this
study only reached 48 mmHg. Ito et al. has shown
that hypercapnia can increase cerebral blood flow by as
much as 6% per mmHg increase in PaCO2[10]. This
means that the cleansing effect that cerebral blood flow
provides was not available to the same degree for these
patients as those in the other study. Also, the remifentanil
infusion was turned off 10 min before the desflurane was
discontinued in the other study; in our study they were
both turned off at the end of surgery. The remifentanil
still present in the the patient’s system and the possibility
that it reacted with desflurane may have increased the
emergence time in this study.
In the PACU, however, the effects of hypercapnia and
hyperventilation seem to have carried over from the OR
since treated patients, in general, reached each stage
of recovery sooner than the control group. Hypercapnic
patients also experienced less nausea and required fewer
rescue antiemetics.
Two mechanisms are responsible for the decrease in
emergence and recovery time: increased cerebral blood
flow, caused by increased PaCO2 hypercapnia; and in-
creased ventilation, which removes anesthetic quickly
from the lungs, decreasing the alveolar concentration and
increasing the concentration gradient between arterial
blood and brain tissue[10], [11], [12]. A patient with
lower anesthetic levels and increased ventilation drive
due to hypercapnia may have faired better in the PACU
because they were more awake, oriented, and able to
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Fig. 3. The top charts show the amount of nausea experience by each patient in the PACU, ranked by severity where the dark gray bars
indicate moderate nausea and the light gray mild nausea. The bottom charts show the corresponding antiemetic doses administered to the
patients in the top charts during their time spent in the OR and PACU. The dosage amounts are as follows: ondansetron 4 mg, promethazine
12.5 mg, droperidol 0.625 mg, famotidine 20 mg, metoclopramide 10 mg. The left charts show the patients in the control group; the right
show the hypercapnic or treatment group.
interact with PACU nurses in addressing their needs.
It has been hypothesized that “high inspired-oxygen
concentrations may counter the tissue hypoxia resulting
from surgical manipulation, thereby preventing serotonin
release,” which is believed to be one of the factors
affecting the nausea and vomiting centers in the nervous
system—especially during abdominal surgery[13]. Greif
et al. found that patients undergoing colon resection
who received 80% inspired oxygen during surgery and
2 hours postoperatively and no prophylactic antiemetics
experienced twice the reduction in postoperative nausea
and vomiting compared to those that received only 30%
inspired oxygen[14]. Fleischmann et al. and Ratnaraj et
al. both have shown that hypercapnia with high concen-
trations of inspired oxygen aid in subcutaneous, colonic,
and intestinal oxygenation[15], [16]. The reduction of
nausea and vomiting seen in this study may be the
result of a similar phenomenon where hypercapnia and
high concentrations of inspired oxygen provide adequate
oxygenation to the tissues being manipulated during
surgery so as to suppress the release of serotonin that
occurs when tissue becomes hypoxic. Future studies
could verify the link between oxygenation and nausea
in patients undergoing eye surgery since this type of
surgery is known to produce a high frequency of nausea
and vomiting.
STUDY 2
Methods
Pending IRB approval, written informed consent will
be obtained from 44 ASA class I-III patients scheduled
to undergo eye muscle surgery at the John A. Moran
Eye Center. A similar protocol to the previous study
will be followed with just a couple of exceptions:
a more stringent protocol as to the administration of
antiemetics will be used and ondansetron 4mg will be the
preferred rescue antiemetic. Additionally, CO2, O2, and
anesthetic levels as well as tidal volume and respiratory
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rate will be recorded in the PACU during the first
30 min of recovery. Two monitors will be used: the
Capnomac Ultima (Datex, Helsinki, Finland) and Respi-
trace Calibrator (Ambulatory Monitoring, Inc., Ardsley,
NY). The Capnomac Ultima is capable of measuring
five parameters. However, to obtain accurate volume
measurements, the patient must wear a tight fitting mask,
and unfortunately many patients are irritated by even the
loose fitting oxygen mask presently used in the PACU.
Also, supplemental oxygen will most likely be given
to the patient during this process, which will interfere
with the tidal volume measurements. The Respitrace
monitor provides an alternative approach to measuring
tidal volumes.
The Respitrace monitor provides a method of mea-
suring tidal volume and respiratory rate without using
a mask. It measures the expansion of the chest and
abdomen due to breathing using impedance readings
from special elastic bands placed around the patient.
The impedance reading can then be calibrated to produce
volumetric information. With this configuration the tidal
volume and minute volume will be measured using the
Respitrace monitor, and CO2, O2, and anesthetic levels
will be measured using the Capnomac Ultima through a
nasal cannula.
Custom software has been developed to integrate the
two monitors into one system that will sample and record
relevant information from both monitors simulaneously.
Both monitors have analog outputs that can be sampled
using the USB-1208LS analog-to-digital converter (Mea-
surement Computing, Middleboro, MA). To calibrate the
Respitrace, the patient must breath into a mouth piece
for 15 seconds so that flow data can be recorded using
the Capnomac Ultima.
Once the initial calibration is made, data will be
gathered for the first 30 min the patient spends in the
PACU. Recalibration will occur every 5 minutes since
the calibration can altered if the patient moves too much.
This will also provide at least 5 direct measurements of
gas volumes and concentrations in case the nasal cannula
or elastic bands fail to record accurately.
CONCLUSIONS
Hypercapnia after anesthesia with desflurane does
reduce emergence time, and the effects of hypercapnia
carry over to the PACU where a patient seems to pass
through the phases of recovery sooner with less nausea.
Our upcoming study will further quantify the pro-
longed effects of a hypercapnic emergence. The data
collected in the PACU regarding a patient’s respiratory
parameters will be of great interest since little has been
published concerning this aspect of recovery.
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